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of food resources, leading to decreased fitness in mam-
malian wildlife, is discussed, as well as possible negative 
effects in humans. However, a possibility to utilize PFOA-/
PFOS-like substances for activating UCP1 therapeutically 
in obesity-prone humans may also be envisaged.
Keywords Uncoupling protein 1 · Brown adipose 
tissue mitochondria · Environmental pollution · Reactive 
oxygen species · Membrane potential · Mitochondrial 
permeabilization
Introduction
Perfluorinated compounds have been utilized in a wide 
variety of commercial products, due to their unique surface 
active properties, the stability of their C–F bonds, and their 
thermal resistivity. These products include grease-resist-
ant food wrapping, firefighting foams, and ski wax. Due 
to their stability, perfluorinated compounds accumulate 
in nature, and the presence of perfluorinated compounds 
in the environment and in bodily fluids of humans and 
wildlife has been well documented (Beesoon et al. 2012; 
Kannan et al. 2006; Theobald et al. 2011; Zhang et al. 
2013). Although there is much concern that the perfluori-
nated compounds may present a health risk to animals and 
humans, there are relatively few studies concentrating on 
the biological effects of these compounds.
The most common perfluorinated compounds are per-
fluorooctanoate (PFOA) and perfluorooctane sulfonate 
(PFOS), i.e., the fatty acid octanoic acid structure in which 
all hydrogen atoms are exchanged for fluorine and the simi-
larly altered octanoic sulfonate structure (shown in Online 
Resource 1). Being structurally similar to a fatty acid, the 
possibility may be raised that PFOA and PFOS exhibit 
Abstract The metabolically inert perfluorinated fatty 
acids perfluorooctane sulfonate (PFOS) and perfluorooc-
tanoate (PFOA) can display fatty acid-like activity in 
biological systems. The uncoupling protein 1 (UCP1) in 
brown adipose tissue is physiologically (re)activated by 
fatty acids, including octanoate. This leads to bioenergeti-
cally uncoupled energy dissipation (heat production, ther-
mogenesis). We have examined here the possibility that 
PFOA/PFOS can directly (re)activate UCP1 in isolated 
mouse brown-fat mitochondria. In wild-type brown-fat 
mitochondria, PFOS and PFOA overcame GDP-inhibited 
thermogenesis, leading to increased oxygen consumption 
and dissipated membrane potential. The absence of this 
effect in brown-fat mitochondria from UCP1-ablated mice 
indicated that it occurred through activation of UCP1. A 
competitive type of inhibition by increased GDP concentra-
tions indicated interaction with the same mechanistic site 
as that utilized by fatty acids. No effect was observed in 
heart mitochondria, i.e., in mitochondria without UCP1. 
The stimulatory effect of PFOA/PFOS was not secondary 
to non-specific mitochondrial membrane permeabilization 
or to ROS production. Thus, metabolic effects of perfluori-
nated fatty acids could include direct brown adipose tissue 
(UCP1) activation. The possibility that this may lead to 
unwarranted extra heat production and thus extra utilization 
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properties akin to those of natural fatty acids—but due to 
their non-metabolizability, the effects would be persistent 
and metabolically irreversible.
A very conspicuous property of fatty acids is their ability 
to (re)activate UCP1, i.e., the brown fat-specific mitochon-
drial membrane protein that endows brown adipose tissue 
with its ability to produce heat, i.e., non-shivering thermo-
genesis (Cannon and Nedergaard 2004; Nicholls and Locke 
1984). As this occurs through combustion of fat, activa-
tion of this process may result in body fat loss. Indeed, it 
has been shown that PFOA/PFOS supplementation to the 
food led to a marked decrease in mice body weight and in 
the mass of white adipose tissue depots (Xie et al. 2002, 
2003). We have therefore examined here the possibility that 
PFOA/PFOS can mimic the effect of natural fatty acids 
by specifically activating UCP1. As this proved to be the 
case, the possibility exists that high environmental levels 
of PFOA/PFOS may affect the metabolism of animals and 
humans through this mechanism, resulting in decreased 
metabolic efficiency and potentially decreased fitness.
Materials and methods
Animals
UCP1(−/−) mice (= UCP1 KO mice) (progeny of those 
described in Enerbäck et al. (1997)) have been backcrossed 
to C57Bl/6 for 10 generations, and after intercrossing, they 
were maintained as a strain, in parallel with the wild-type 
C57Bl/6 mice. The mice were fed ad libitum (R70 Stand-
ard Diet, Lactamin), had free access to water, and were kept 
on a 12:12-h light–dark cycle, routinely at normal (22 °C) 
animal house temperature. The experiments were approved 
by the Animal Ethics Committee of the North Stockholm 
region.
Mitochondrial preparation
Brown-fat and liver mitochondria were prepared as 
described (Cannon and Nedergaard 2008; Shabalina et al. 
2010). Routinely, on each experimental day, three mice 
were anaesthetized for 1–2 min by a mixture of 79 % CO2 
and 21 % O2 and decapitated. The interscapular, periaortic, 
axillary, and cervical brown adipose tissue depots were dis-
sected out, cleaned from white adipose tissue, and pooled 
in ice-cold 250 mM sucrose solution. Throughout the isola-
tion process, the tissue was kept at 0–4 °C. The tissue was 
minced with scissors, homogenized in 250 mM sucrose 
solution, filtered through gauze, and centrifuged at 8500g 
for 10 min. The supernatant with the floating fat layer was 
discarded. The resuspended homogenate was centrifuged 
at 800g for 10 min, and the resulting supernatant was 
centrifuged at 8500g for 10 min. The resulting mitochon-
drial pellet was resuspended in 100 mM KCl, 20 mM K+–
Tes (pH 7.2), 1 mM EDTA, 0.6 % fatty acid-free BSA, and 
centrifuged again at 8500g for 10 min. The final mitochon-
drial pellets were resuspended by hand homogenization in 
a small glass homogenizer in the same medium.
Heart mitochondria were isolated principally as brown-
fat mitochondria with some modifications described in 
Online Resource 4.
Oxygen consumption, membrane potential, 
and swelling
Functions of isolated mitochondria were analyzed as 
described (Shabalina et al. 2004, 2013). For oxygen con-
sumption measurements, isolated mitochondria (0.3 mg 
protein) were added to 1.0 ml of a continuously stirred incu-
bation medium consisting of 100 mM KCl, 20 mM K+–Tes 
(pH 7.2), 2 mM MgCl2, 1 mM EDTA, 4 mM KPi, 3 mM 
malate, and 0.1 % fatty acid-free BSA. The substrate was 
5 mM pyruvate. Oxygen consumption rates were monitored 
with a Clark-type oxygen electrode (Yellow Springs Instru-
ment Co) in a sealed chamber at 37 °C. The output signal 
from the oxygen electrode amplifier was electronically 
time-differentiated and collected every 0.5 s by a Power-
Lab/ADInstrument (application program Chart v5.1.1.). The 
Chart data files were transferred to the KaleidaGraph Mac-
intosh application and converted to absolute values, based 
on an oxygen content of 217 nmol of O2 per 1 ml of water 
and on the amount of mitochondrial protein used. For calcu-
lation of stable oxygen consumption rates, mean values dur-
ing about 1 min were obtained from these recordings.
Mitochondrial membrane potential measurements were 
performed with the dye safranin O (Nedergaard 1983; 
Shabalina et al. 2006b) under the same conditions as those 
used for oxygen consumption. The changes in absorbance 
of safranin O were followed at 37 °C in an Olis® modern-
ized Aminco DW-2 dual-wavelength spectrophotometer at 
511–533 nm with a 3-nm slit. Olis GlobalWorks™ soft-
ware was used for recording and quantification.
Mitochondrial swelling was monitored as the change in 
absorbance at 540 nm with a 3-nm slit in an Olis® modern-
ized Aminco DW-2 spectrophotometer as described (Silva 
et al. 2005). The mitochondrial incubation medium and the 
experimental conditions were those described for oxygen 
consumption.
Mitochondrial hydrogen peroxide production
Mitochondrial H2O2 net production was determined fluo-
rometrically with the Amplex Red reagent principally as 
described (Shabalina et al. 2014). Mitochondria were incu-
bated under the same conditions as those used for oxygen 
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consumption in the presence of 50 µM palmitoyl CoA, 
5 mM dl-carnitine, and 1 mM GDP. All incubations also 
contained 5 µM Amplex Red, 12 units ml−1 horseradish 
peroxidase, and 30 units ml−1 superoxide dismutase. The 
increase in fluorescence was detected with an EnSpire® 
Multimode Plate Reader (PerkinElmer) in 24-well plates. 
The excitation wavelength was set to 563 nm, and the 
fluorescence emission was detected at 584 nm. The rate 
of H2O2 production was calculated as the change in fluo-
rescence intensity during 2 min of the linear phase as 
described (Shabalina et al. 2014). Calibration curves were 
obtained by adding known amounts of freshly diluted H2O2 
(the concentration of stock solution was checked at 240 nm 
using a molar extinction coefficient of 43.6) to the assay 
medium. The standard curve was linear in a range up till 
500 nM H2O2. The calibration was performed also in the 
presence of GDP, substrates, PFOA, PFOS, and octanoic 
acid; no additions had any effect on the calibration.
Chemicals
Fatty acid-free bovine serum albumin (BSA), fraction V, 
was from Roche Diagnostics GmbH. Amplex Red was from 
Life Technologies. Rotenone, FCCP [carbonyl cyanide 
p-(trifluoro-methoxy)-phenylhydrazone], GDP (guanosine 
5′-diphosphate) (sodium salt), pyruvic acid (sodium salt), 
L(−) malic acid (disodium salt), palmitoyl coenzyme A 
(lithium salt), dl-carnitine HCl, safranin O, EDTA (ethylen-
ediamine tetraacetic acid), horseradish peroxidase, alame-
thicin, PFOA (perfluorooctanoic acid), PFOS (perfluorooc-
tane sulfonic acid) (tetraethylammonium salt), and octanoic 
acid (sodium salt) were all from Sigma-Aldrich Co. PFOS, 
PFOA, and octanoate were dissolved in 20 mM K+–Tes (pH 
7.2) with 5 % ethanol. GDP was dissolved in 20 mM Tes 
(pH 7.2), and the pH of the solution was readjusted to 7.2. 
FCCP was dissolved in 95 % ethanol and diluted in 50 % 
ethanol. Ethanol in a final concentration of 0.1 % did not in 
itself have any effects on the parameters measured.
Statistics
All data are expressed as means ± standard errors. Statis-
tical analysis for the comparison of two groups was per-
formed using Student’s t test.
Results
PFOA and PFOS activate UCP1‑dependent 
thermogenesis in brown‑fat mitochondria
In order to examine whether the fatty acid-like perfluori-
nated compounds PFOA and PFOS could specifically 
interact with UCP1-mediated thermogenic processes in 
brown-fat mitochondria, we isolated brown-fat mitochon-
dria from wild-type and UCP1 KO mice. We first con-
firmed the characteristic bioenergetics of these isolated 
mitochondria (Fig. 1a). In brown-fat mitochondria without 
UCP1 (thin trace), the basal respiration was low even in 
the presence of substrate in the form of pyruvate, and the 
addition of GDP did not affect the respiration. Subsequent 
addition of the artificial protonophore FCCP markedly 
increased the respiration. In brown-fat mitochondria with 
UCP1 (wild type) (heavy trace), the initial rate of respira-
tion was high as expected, and it was reduced threefold to 
fourfold by GDP, in agreement with this high respiration 
being mediated by UCP1. The innately active UCP1 and 
the inhibition of the UCP1 activity by GDP are fundamen-
tal properties of brown-fat mitochondria, distinguishing 
them from mitochondria from any other tissue (Jimenez-
Jimenez et al. 2006; Matthias et al. 1999; Monemdjou et al. 
1999; Nicholls 1976; Shabalina et al. 2010).
The sensitivity of the mitochondria to FCCP was unaf-
fected by the presence or absence of UCP1 (Fig. 1a). Thus, 
in brown-fat mitochondrial preparations such as these, 
wild-type and UCP1 KO mitochondria have equal oxida-
tive capacities (reflected in the response to FCCP), and the 
absence of UCP1 is the limitation for thermogenesis.
Within unstimulated brown-fat cells, UCP1 is inhibited 
by cytosolic nucleotides (ATP, ADP, GTP and GDP) (Can-
non and Nedergaard 2004; Nicholls and Locke 1984; Shab-
alina et al. 2004), and this inhibition is what is demonstrated 
with GDP in Fig. 1a. In vivo, fatty acids that are released 
from the stored triglycerides during adrenergic stimulation 
are believed to be the major reactivators of UCP1 (Cannon 
and Nedergaard 2004; Nicholls and Locke 1984; Shabalina 
et al. 2008, 2004). The following experiments were there-
fore designed to investigate whether PFOA/PFOS possesses 
the ability to overcome the GDP inhibition demonstrated 
above, i.e., to reactivate UCP1. We also compared PFOA/
PFOS with the characteristics of octanoic acid, being the 
corresponding natural fatty acid, i.e., the fatty acid with the 
same number of carbons as PFOA/PFOS but with hydrogen 
replacing the fluorine molecules.
We initially observed that in brown-fat mitochondria 
without UCP1, PFOA induced a measurable but only minor 
increase in the respiration (Fig. 1b, thin trace). The high 
stimulatory effect of FCCP (Fig. 1b, thin trace) indicated 
that the mitochondria retained their high oxidative capacity 
(the inability of PFOA to stimulate respiration was thus not 
due to an inhibitory or toxic effect on mitochondrial respi-
ration per se).
In mitochondria with UCP1 (Fig. 1b, heavy trace), 
where UCP1 activity had been inhibited by GDP, an effect 
of PFOA on oxygen consumption was visible already at 
low PFOA concentrations. The effect was much more 
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pronounced than in the UCP1 KO mitochondria, with clear 
saturation kinetics. Also in these wild-type mitochondria, 
it was possible to expose the full oxidative capacity of the 
mitochondria by FCCP addition. A compilation (Fig. 1c) of 
experiments such as that shown in Fig. 1b clearly demon-
strated that the presence of UCP1 mediated higher sensi-
tivity to PFOA, i.e., PFOA is apparently able to reactivate 
UCP1.
We performed similar experiments with the analog 
PFOS. In the compilation in Fig. 1d, it is seen that PFOS 
was also able to reactivate UCP1 after GDP inhibition. 
However, the curve shape was not simple. It reached a 
maximum at 320 µM PFOS, and the effect then declined. 
As discussed in more detail below, this decline was related 
to an inhibitory effect of PFOS on the respiratory chain 
activity. Due to this double effect of PFOS, most of the fol-
lowing studies were only performed with PFOA.
To investigate whether the effect of PFOA/PFOS was 
mechanistically similar to that of a fatty acid, we compared 
the uncoupling ability of PFOA/PFOS with that of octanoic 
acid (Fig. 1e). As seen, also octanoic acid induced a meas-
urable but only minor increase in respiration in brown-fat 
mitochondria without UCP1. Thus, there was a parallel 
ability (see Online Resource 2b) of octanoic acid, PFOA, 
and PFOS to induce such an UCP1-independent respira-
tion. The molecular background for such fatty acid-induced 
respiration is not fully known. It is often referred to as a 
carrier-mediated uncoupling, but our earlier studies in 
brown-fat mitochondria indicate that it is only to the small 
degree mediated by activation of the adenine nucleotide 
Fig. 1  PFOA-/PFOS-stimulated 
oxygen consumption: depend-
ence on UCP1. Representative 
traces showing the effects of 
FCCP (a) and PFOA (b) on 
oxygen consumption in brown 
adipose tissue mitochondria 
(M, 0.3 mg/ml) from UCP1 KO 
(thin line) or wild-type (WT) 
(heavy line) mice. Additions 
were 5 mM pyruvate (Pyr), 
1 mM GDP, and 0.7–2.1 µM 
FCCP (added successively). 
PFOA was successively added 
in the concentration range 
80–480 µM (each addition 
was 80 µM). c Compilation of 
the effect of PFOA, based on 
experiments as those shown 
in b. Concentration–response 
curve of PFOS (d) and octanoic 
acid (e) in brown-fat mito-
chondria from UCP1 KO or 
WT mice. Mitochondria were 
examined as shown for PFOA in 
b, except that not all concentra-
tions of PFOS were examined in 
UCP1 KO. f UCP1-dependent 
effects of PFOA, PFOS, and 
octanoic acid on oxygen 
consumption. The values were 
obtained by subtraction of the 
means of effects in UCP1 KO 
mitochondria from the cor-
responding means of effects in 
wild-type mitochondria. The 
points in c–f are mean ± SE of 
4–8 independent mitochondrial 
preparations for each group. 
*Difference between genotypes 
(two symbols P < 0.01, three 
symbols P < 0.001)
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translocator, in contrast to what it is in other tissues (Shaba-
lina et al. 2006a).
Octanoic acid is a fairly potent UCP1 activator in pri-
mary brown adipocytes (Shabalina et al. 2008) and in 
reconstituted UCP1 systems (Winkler and Klingenberg 
1994). Our results confirmed that octanoate activates UCP1 
also in isolated brown-fat mitochondria (Fig. 1e).
In order to mathematically obtain the UCP1-dependent 
effect of PFOA, PFOS and octanoic acid, the effect of 
these substances in UCP1 KO mitochondria was subtracted 
from the effect in wild-type mitochondria (Fig. 1f). This 
clearly showed that the magnitude of the UCP1-dependent 
effects of both PFOA and PFOS was larger than the effect 
of octanoate (Fig. 1f). Due to their unquantified interac-
tion with albumin, the free concentrations of the substances 
cannot be calculated, and true affinities can therefore not 
be determined; however, in nominal values, PFOA/PFOS 
seems to have higher affinities for UCP1 than does octa-
noic acid (Km 162 for PFOA vs. 399 µM for octanoic acid). 
Also the maximal effect seems to be higher (Vmax 51 nmol 
O2 per min per mg vs. 32) (Online Resource 2 and 3).
Thus, PFOS and PFOA specifically activate UCP1 in 
isolated brown-fat mitochondria, and their ability to appar-
ently induce UCP1-mediated extra oxygen consump-
tion (“uncoupling”) was greater than that of the fatty acid 
octanoate of the same chain length. Thus, exchanging the 
hydrogens on octanoic acid with fluorine makes the C8 
carbon skeleton more competent, principally making the 
octanoic acid appear as a longer fatty acid—as longer fatty 
acids have higher uncoupling abilities (Bukowiecki et al. 
1981; Fedorenko et al. 2012; Shabalina et al. 2008).
A functionally competitive interaction between GDP 
and PFOA
The data above demonstrated that PFOA/PFOS were able 
to interact with brown-fat mitochondria in a UCP1-depend-
ent manner. The data do not, however, demonstrate that 
PFOA/PFOS and fatty acids interact with UCP1 mechanis-
tically at the same site. Characteristically, fatty acids reac-
tivate UCP1 in a manner that is functional competitive with 
GDP (Fedorenko et al. 2012; Shabalina et al. 2004). [How 
this interaction occurs molecularly is not known; it would 
not seem to be via a direct physical competition between 
GDP and fatty acid on one binding site (Rial et al. 1983)]. 
To examine whether PFOA/PFOS shared these mechanis-
tic interaction characteristics, we compared the reactivation 
competence of PFOA in the presence of 3 versus 1 mM 
GDP. As seen in Fig. 2a, the increased GDP level markedly 
influenced the kinetics. The much flatter curve shape indi-
cated a much lower apparent affinity of PFOA for the inter-
action site, in agreement with a functionally competitive 
interaction. We therefore conclude that the interaction of 
PFOA/PFOS with UCP1 is of the same mechanistic nature 
as that of true fatty acids.
Effect of PFOA is probably not secondary to release 
of fatty acids
It may be suggested that PFOA/PFOS do not interact 
directly with UCP1 but that the effect is secondary, i.e., 
through a PFOA-/PFOS-induced release of UCP1 acti-
vators, such as free fatty acids that are bound to albu-
min or fatty acids released from the mitochondrial mem-
brane. Such a mechanism has earlier been proposed for 
the effect of acyl sulfonates on mitochondria (Jezek et al. 
2006; Simonian et al. 2006). To approach this question, we 
titrated PFOA in the presence of added palmitate. Some 
of this added palmitate would bind to the albumin where 
Fig. 2  Effect of GDP and palmitate on PFOA-stimulated oxygen 
consumption in wild-type brown-fat mitochondria. a The effect of 
increased GDP concentration (from standard 1 mM to 3 mM) on the 
concentration–response curve for PFOA. Mitochondria were exam-
ined principally as shown in Fig. 1b. The points are mean ± SE of 
3 independent mitochondrial preparations. ** Indicates significant 
difference (P < 0.01) with paired t test. b The effect of palmitate 
(20 µM) on the concentration–response curve for PFOA was also 
examined principally as in Fig. 1b. The points are mean ± SE of 2 
independent mitochondrial preparations
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it could then be competed out by PFOA. The consequence 
should be that the presence of palmitate should enhance the 
effect of a given PFOA addition.
In Fig. 2b, a comparison is shown between the dose–
response curves for PFOA in the presence and absence of a 
small amount of added palmitate. As expected, there was a 
constant effect at each PFOA concentration of the addition 
of the small amount of palmitate, but otherwise the PFOA 
dose–response curve paralleled the curve in the absence of 
added palmitate. There was thus no enhancing effect of the 
presence of extra palmitate. This makes it less likely that 
the effect of PFOA on oxygen consumption in brown-fat 
mitochondria is a secondary effect; rather, PFOA/PFOS 
probably interact themselves directly with UCP1.
Tissue specificity of PFOA effect
The above data indicate that PFOA interacts specifically 
with UCP1. As UCP1 is only found in brown adipose tis-
sue (and in the functionally similar brite/beige cells in cer-
tain white adipose tissue depots), the implication would be 
that the effect should not be observable in any other tissue. 
To substantiate this, we tested the effect of PFOA on mito-
chondria isolated from heart tissue (Online Resource 4). 
Concerning the effect of PFOA on oxygen consumption, 
the trace (Online Resource 4a) showed an interaction of 
PFOA with these mitochondria that was very similar to that 
of PFOA interaction with brown-fat mitochondria lack-
ing UCP1 (UCP1 KO), shown in Fig. 1b. Thus, no UCP1-
like effects were visible in the heart mitochondria. Corre-
spondingly, PFOA did not affect the membrane potential 
(see below) of these mitochondria (Online Resource 4b). 
Thus, there is no reason to believe that the effects of PFOA 
observed in wild-type brown-fat mitochondria would be 
paralleled by similar effects in other tissues.
Effect of PFOA/PFOS on mitochondrial membrane 
potential
The increased oxygen consumption observed above in 
wild-type brown-fat mitochondria should, according to 
Mitchellian principles, be fully due to a decrease in mem-
brane potential, as caused by increased membrane per-
meability for protons (equivalents). To establish whether 
PFOA/PFOS induced this type of classical mitochondrial 
uncoupling, we followed the membrane potential in these 
mitochondria with the safranin O technique (Nedergaard 
1983), as exemplified in Fig. 3a. As seen, in the presence 
of GDP, the membrane potential in wild-type and in UCP1 
KO brown-fat mitochondria reached the same high level 
(Fig. 3a), as earlier observed (Shabalina et al. 2006b, 2010). 
In UCP1 KO mitochondria, the signal was only weakly 
diminished by addition of PFOA (thin line). However, in 
wild-type mitochondria, the signal was markedly and dose-
dependently decreased by PFOA (heavy line). FCCP and 
the artificial permeabilization agent alamethicin could dis-
sipate the signal both in wild-type and UCP1 KO (Fig. 3a).
The safranin O data calculated as membrane poten-
tial are shown in Fig. 3b, c, and the relationship between 
membrane potential and oxygen consumption is also shown 
(oxygen consumption data from experiments as those in 
Fig. 1 but performed in parallel with the membrane poten-
tial measurements). As seen, the relationship between 
membrane potential and oxygen consumption was practi-
cally identical irrespective of whether PFOA exerted its 
small effect in UCP1 KO mitochondria or whether it func-
tioned through activation of UCP1.
Similarly, we examined the effect of PFOS on membrane 
potential (Fig. 3d), in comparison with that of the natu-
ral reactivator octanoic acid. As expected, PFOS induced 
a much greater decrease in membrane potential than did 
octanoic acid. PFOS even induced a higher drop in poten-
tial than did PFOA (compare Fig. 3a and d). The reason for 
this became evident when we further examined the func-
tion of the mitochondria in traces such as that in Fig. 3e. It 
can be seen that the successive additions of PFOS initially 
gave rise to an increasing rate of oxygen consumption, but 
at higher concentrations, this was no longer the case; rather 
the effect became inhibitory, and FCCP can no longer over-
come the inhibition. Thus, when oxygen consumption is 
plotted as a function of membrane potential (Fig. 3f), the 
relationship is initially the same for octanoic acid and for 
PFOS (at higher potentials). However, the curve is not 
monotonic, and at the highest PFOS concentrations, a fur-
ther depolarization is accompanied by diminished oxygen 
consumption. Thus, PFOS has an inhibitory effect on the 
respiratory chain.
In brown-fat cells, the stimulatory effect of fatty acids to 
(re)activate UCP1 is strongly dependent on fatty acid chain 
length (Bukowiecki et al. 1981; Shabalina et al. 2008). Our 
observation that the magnitude of the PFOA/PFOS effect 
on the membrane potential was greater than the magnitude 
of that of the fatty acid of the same chain length (octanoic 
acid) was therefore intriguing. It principally could be seen 
to imply that the fluorinated fatty acids are experienced by 
UCP1 as being of a longer chain length than the native fatty 
acids, i.e., the uncoupling potency is not a function of the 
physical length of the carbon chain.
PFOA‑/PFOS‑induced activation of respiration is not 
caused by mitochondrial disintegration
An ability of PFOA/PFOS to induce mitochondrial per-
meabilization has been previously shown both on the cel-
lular level (Kleszczynski et al. 2009; Panaretakis et al. 
2001) and on isolated mitochondrial level (O’Brien and 
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Fig. 3  Effect of PFOA/PFOS on membrane potential in brown-fat 
mitochondria. a Representative traces showing the effects of PFOA 
on membrane potential (safranin O absorbance) in brown-fat mito-
chondria isolated from UCP1 KO (thin line) or wild-type (heavy 
line) mice. 5 mM pyruvate and 1 mM GDP were added before start 
of trace recording. Further additions in a were 0.25 mg/ml brown-
fat mitochondria (BM), 2 µM FCCP and 0.02 mg/ml alamethicin 
(Ala). PFOA was added successively to obtain concentrations of 
80–400 µM (each addition was 80 µM). b Effect of increasing PFOA 
concentrations on membrane potential in brown-fat mitochondria 
from wild-type and UCP1 KO mice. Data from experiments as in a 
were recalculated as membrane potentials (detailed in (Nedergaard 
1983; Shabalina et al. 2014). c Oxygen consumption as an effect 
of membrane potential. Data from b were plotted with the corre-
sponding values for oxygen consumption. To allow for direct com-
parisons, all corresponding results are from one experimental day, 
with parallel mitochondrial preparations of wild-type and UCP1 
KO mitochondria, examined in parallel for respiration (as in Fig. 1) 
and membrane potential. The points in b and c are mean ± SE of 
4 independent mitochondrial preparations for WT and 2 prepara-
tions for UCP1 KO group. In b, asterisks indicate significant differ-
ences between wildtype and UCP1 KO mitochondria (one symbol 
P < 0.05, two symbiols P < 0.01). d Representative traces showing 
the effect of PFOS and octanoic acid on membrane potential in wild-
type brown-fat mitochondria. Conditions are as in a. e Representative 
traces showing the effect of PFOS and octanoic acid on oxygen con-
sumption in wild-type brown-fat mitochondria. Conditions are as in 
Fig. 1b. f Oxygen consumption as an effect of membrane potential. 
As in d, but shown for PFOS and octanoic acid in wild-type brown-
fat mitochondria. The experiment was performed twice on independ-
ent mitochondrial preparation
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Wallace 2004). The UCP1-reactivating effect (“uncou-
pling”) observed in our experiments could thus be dis-
cussed as being due to damage of the mitochondrial 
membrane, associated with swelling of the mitochondria 
(although the tissue specificity and the UCP1-dependence 
of the effect demonstrated above in itself makes this less 
plausible). In order to clarify this, we analyzed whether 
PFOA/PFOS could induce swelling in wild-type brown-
fat mitochondria (Fig. 4a). The addition of nominal 
PFOA/PFOS amounts of up to 320 µM, i.e., the concen-
tration range necessary for the specific UCP1 activation 
(cf. Figs. 1, 3), had no effect on mitochondrial volume 
(Fig. 4a). At higher concentrations, PFOA induced only 
small changes in mitochondrial matrix volume (≈10 % of 
maximal swelling defined as that occurring with alame-
thicin) (Fig. 4b), whereas PFOS caused high-ampli-
tude swelling (up to 77 %) at the highest concentration 
(Fig. 4b). Octanoate did not induce mitochondrial swell-
ing (Fig. 4). Stronger detergent properties of PFOS due to 
the presence of sulfonate group could be responsible for 
stronger swelling-inducing effect of PFOS as compared 
to PFOA. However, clearly, the ability of PFOA/PFOS to 
enhance UCP1-dependent thermogenesis, which occurred 
in the lower concentration range, was not related to any 
induction of mitochondrial swelling.
In Online Resource 5, we examined whether the 
swelling responses were specific for the (UCP1-con-
taining) brown-fat mitochondria or whether similar 
responses could be observed in liver mitochondria. We 
found that liver mitochondria reacted qualitatively simi-
larly to brown-fat mitochondria (high swelling induc-
tion by PFOS, lower by PFOA, and very small effect of 
octanoic acid). However, liver mitochondria were much 
more sensitive to the agents. Our liver results showing 
induction of non-specific permeabilization are consist-
ent with findings of (O’Brien and Wallace 2004; Starkov 
and Wallace 2002), also performed in liver mitochon-
dria. Differences between our study and (Starkov and 
Wallace 2002) in PFOA concentration necessary for the 
effect may be due to the presence of BSA in our media 
for mitochondrial incubation and isolation. The much 
higher sensitivity of liver mitochondria than brown-fat 
mitochondria to the swelling-inducing agents may be 
related to the fact that brown-fat mitochondria contain 
much lower amounts of ATP synthase than does liver 
mitochondria (Kramarova et al. 2008). It is possible 
that the swelling seen is a manifestation of the activa-
tion of the membrane permeability transition pore. This 
pore has been suggested to be formed from dimers of the 
ATP synthase (Giorgio et al. 2013). Thus, lower amounts 
of ATP synthase in brown-fat mitochondria will confer 
lower sensitivity to membrane permeability transition 
pore-inducing agents.
High concentration of PFOA/PFOS induces production 
of mitochondrial reactive oxygen species
PFOA and PFOS are competent inducers of the produc-
tion of reactive oxygen species (ROS) in HepG2 cells 
Fig. 4  Effect of PFOA/PFOS on mitochondrial swelling in brown-fat 
mitochondria. a Representative traces showing the effects of PFOA, 
PFOS and octanoic acid on non-specific mitochondrial permeabiliza-
tion in brown-fat mitochondria isolated from wild-type mice. Pyru-
vate (5 mM) and 1 mM GDP were added before the start of the trace 
recording. Additions were 0.25 mg/ml brown-fat mitochondria, and at 
the end 0.02 mg/ml alamethicin (Ala) (to allow for full mitochondrial 
permeabilization). PFOA, PFOS and octanoic acid were successively 
added to concentrations 80–400 µM (each addition was 80 µM and 
recorded during 2.0–2.5 min). To allow for direct comparisons, all 
traces shown are from one experimental day. b Quantification of the 
amplitude of swelling exactly 2 min after the final addition (400 µM) 
of PFOA or PFOS or octanoic acid. Values are indicated in percent of 
the maximum response [defined as the absorbance difference between 
the starting value (0 concentration) and the value after alamethicin 
addition]. The points are mean ± SE of 3–5 independent mitochon-
drial preparations. *Indicates difference between intact mitochondria 
(swelling is equal to 0) and agent; #Difference between PFOS and 
other tested chemicals (one symbol indicates P < 0.05, two symbols 
P < 0.01)
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(Panaretakis et al. 2001) associated with dissipation of mito-
chondrial membrane potential and apoptosis in these cells 
(Shabalina et al. 1999). As it has been suggested that ROS 
(and ROS-derived molecules) could activate UCP1 (different 
views on this possibility are reviewed in (Brand et al. 2004; 
Cannon et al. 2006), the possibility exists that the UCP1 acti-
vation could be secondary for induction of ROS production.
In order to examine the effect of PFOA and PFOS on 
ROS production in intact mitochondria, we studied brown-
fat mitochondria that were actively respiring on fatty 
acid-derived substrate and coupled by GDP (Fig. 5). Low 
concentrations of either PFOA or PFOS had no effect on 
hydrogen peroxide production in these mitochondria. 
However, high concentrations of PFOA, and especially of 
PFOS, induced ROS production (Fig. 5). Octanoate was 
remarkably inert compared with PFOA and PFOS (Fig. 5). 
Our results indicated that PFOA and PFOS at high con-
centrations are indeed potent inducers of mitochondrial 
ROS production. It is natural to assume that the induction 
of mitochondrial swelling (Fig. 4), the inhibition of mito-
chondrial respiration (Fig. 3), and the increase in ROS pro-
duction observed here are closely related phenomena: All 
display a similar relationship between the acids studied 
here, with octanoic acid being without effect, PFOA hav-
ing a small effect at high concentrations, and PFOS having 
a large effect. It is therefore likely that the ROS production 
results from the inhibition of the mitochondrial respiratory 
chain. We have earlier demonstrated that specific inhibitor 
(rotenone) blockade of brown-fat mitochondrial fatty acid-
supported respiration enhances/induces ROS production 
(Shabalina et al. 2014), and we found that a similar effect of 
rotenone could be observed for the PFOA-/PFOS-induced 
ROS production (not shown). The ROS are therefore prob-
ably derived directly from the NADH dehydrogenase com-
plex. In view of the difference between the concentrations 
of PFOA/PFOS to induce thermogenesis (Fig. 1) and that 
needed to induce ROS production (Fig. 5), the induction by 
PFOA/PFOS of UCP1-dependent thermogenesis does not 
seem to be related to ROS production.
Discussion
In the present investigation, we demonstrate a very specific 
ability of the perfluorinated fatty acids PFOA and PFOS 
to induce oxygen consumption in brown-fat mitochondria 
through activation of UCP1. The interaction with UCP1 
shows mechanistic patterns, including saturation and nucle-
otide sensitivity, that imply that PFOA/PFOS acts through 
the same mechanism as do natural fatty acids in their acti-
vation of UCP1. Our observations are of relevance, both 
theoretically in relation to the understanding of UCP1 
molecular function and practically in relation to possible 
PFOA/PFOS effects environmentally and for human health, 
negatively as well as possibly positively.
Relation of PFOA/PFOS to molecular function of UCP1
Concerning UCP1 function, the present study is a (further) 
accentuation that the chemical requirements for a (re)acti-
vating agent for the protonophoric activity of UCP1 are not 
very high. A broad spectrum of natural fatty acids can do it 
(Bukowiecki et al. 1981; Shabalina et al. 2008; Tomas et al. 
2004), and the present studies demonstrate that even chem-
ically quite different fatty acid-like agents can reactivate. 
There is an interesting parallelism that both carbonyl fatty 
acids and sulfonyl fatty acids can activate UCP1, although 
the mechanism may be discussed (Garlid et al. 2000; Rial 
et al. 2004), just as can both carboxylate perfluorinated 
fatty acids (PFOA) and sulfonate perfluorinated fatty acids 
(PFOS). It is also evident that further metabolism of the 
(re)activating fatty acids is not necessary: neither PFOA 
nor PFOS can be further metabolized, just as is the case 
for the non-metabolizable fatty acid analog, Medica 16 
(β,β’-methyl-substituted hexadecane α,ω-dicarboxylic 
acid) (Hermesh et al. 1998)) that is also a UCP1 (re)acti-
vator without being metabolizable (Shabalina et al. 2008). 
Whether the formation of the activated compound—i.e., 
the CoA ester—is possible for PFOA/PFOS (or Medica 
16) is somewhat uncertain, and it cannot be completely 
excluded that the activated compounds could be formed 
and are those that interact with UCP1.—It is also of great 
Fig. 5  Effects of PFOA/PFOS on ROS production in brown-fat mito-
chondria. Mitochondrial H2O2 net production was determined fluo-
rometrically with the Amplex Red reagent as detailed in Methods. 
PFOA, PFOS or octanoic acid were added in aliquots of 80 µM to 
wild-type brown-fat mitochondria. The points are mean ± SE of 4–7 
independent mitochondrial preparations. *Difference between 0 con-
centration and other concentrations of PFOA; °Difference between 0 
concentration and other concentrations of PFOS; # Indicates differ-
ence between PFOA/PFOS and octanoic acid (one symbol indicates 
P < 0.05, two symbols P < 0.01)
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interest to realize that the (re)activation potency of PFOA/
PFOS is much higher than that of the corresponding non-
substituted fatty acid octanoic acid. Although PFOA/PFOS 
have nominally higher affinities for UCP1 than octanoic 
acid (Figs. 1, 3 and Online Resource 2 and 3), the lower 
potency of octanoic acid is not due to an inability to reach 
saturated effects, as saturation is reached for all compounds 
in the present studies. Rather, the potency of a (re)activat-
ing agent is clearly more than just a function of carbon 
chain length.
Possible negative environmental effects
The immediate implication of the present studies would be 
that PFOA/PFOS found in the environment and taken up by 
animals that possess brown adipose tissue could seriously 
affect the energy balance of these animals. This is because 
PFOA/PFOS would plausibly be able to activate UCP1 in 
situ and thus induce an unwarranted extra heat production.
Although it may spontaneously be feared that the prob-
lem with an extra, PFOA-/PFOS-induced heat produc-
tion should be worst when high heat generation is needed 
and resources are small, this may not be the case. This is 
because the activity of brown adipose tissue is well regu-
lated physiologically, and any extra heat generated, in 
brown adipose tissue or elsewhere in the body, will result 
in a compensatory decrease in the sympathetic activation 
of brown adipose tissue (Goldgof et al. 2014; Nedergaard 
and Cannon 2014; Shemano and Nickerson 1958). Instead, 
the problem may arise under warmer conditions where the 
animal would normally fully abolish cold-induced thermo-
genesis. If there is then an artificial extra heat production/
energy utilization, the animal has no ability to compensate 
by decreasing physiological brown fat activation, and it 
will have to maintain a higher energy expenditure than that 
required for survival. During critical times of the year—
viz. late spring when temperatures may be high but food 
abundance still low—this would place an extra strain on the 
animal which may result in diminished fitness. This may be 
particularly relevant for predators that experience biomag-
nification of perfluorinated compounds. What concentra-
tions of PFOA/PFOS that will be encountered in nature as 
compared to those utilized here cannot easily be answered 
presently.
Such possible unwarranted activation of UCP1 would 
indeed also be relevant for humans. Brown adipose tissue is 
found and is active in newborns and infants. There is good 
reason to think that newborns and small infants are exposed 
to perfluorinated compounds. Breast milk contains per-
fluorinated compounds and is the main source of these in 
infants (Haug et al. 2011), and the concentration in breast 
milk (in the Stockholm area) increased during the last quar-
ter of the last century (Sundstrom et al. 2011). There is a 
negative correlation between cord blood levels of perfluori-
nated compounds and body weight in human newborns 
(Apelberg et al. 2007). There is a possibility that this may 
be due to in utero activation of brown adipose tissue in the 
fetus.
Possible therapeutic effects
Presently, for mankind in general, it is not a lack of food 
energy that is a major problem but rather a surplus of 
energy intake leading to obesity. The realization of the 
presence of brown adipose tissue in adult man (Nedergaard 
et al. 2007) has indeed promoted suggestions that a (re)acti-
vation of brown adipose tissue may be helpful in amelio-
ration of the obesity problem (Cereijo et al. 2015; Neder-
gaard and Cannon 2010). We have demonstrated here that 
PFOA/PFOS possess the ability to directly activate UCP1 
with high affinity, as compared to the effects of these com-
pounds on mitochondrial integrity and mitochondrial ROS 
production. Based on the observations here on PFOA/
PFOS and earlier observations on a similar effect of reti-
noic acid on brown-fat mitochondria (Matthias et al. 2000; 
Rial et al. 1999; Shabalina et al. 2008; Tomas et al. 2004), 
there may therefore exist a possibility to use the informa-
tion on these types of compounds to enable development 
of substances that selectively activate UCP1, in the absence 
of chronic sympathetic stimulation. Such substances would 
not be able to recruit brown adipose tissue, and they would 
have to rely on available substrates for combustion. How-
ever, the amount of UCP1 could be increased through other 
pharmaceutical avenues. Under such conditions, such com-
pounds would have a function, in being able to maintain the 
activity of the innately inactive UCP1.
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